The history of rhesus prophylaxis with anti-D

A. Wegmann,R. Ghick

DOI: https://doi.org/10.1007/BF02282831

1996-10-01

European Journal of Pediatrics

Abstract:

What problem does this paper attempt to address?

Genetic Variants of PICALM Rs541458 Modulate Brain Spontaneous Activity in Older Adults with Amnestic Mild Cognitive Impairment

Liying Zhuang,Xiaoyan Liu,Yongmei Shi,Xiaoli Liu,Benyan Luo

DOI: https://doi.org/10.3389/fneur.2019.00494

IF: 3.4

2019-01-01

Frontiers in Neurology

Abstract:Background: Phosphatidylinositol binding clathrin assembly protein (PICALM) rs541458 C allele has been identified and validated to be associated with a reduction of Alzheimer's disease (AD) risk. Nevertheless, the exact mechanisms through which the variant exert its disease-relevant association remain to be elucidated. This study is to determine whether PICALM rs541458 polymorphism modulates functional magnetic resonance imaging measured brain spontaneous activity in older adults with amnestic mild cognitive impairment (aMCI). Methods: Thirty five aMCI patients and twenty six healthy controls (HC) were enrolled in this study. Each individual was genotyped for rs541458 and scanned with resting-state functional magnetic resonance imaging. Each group was divided into two subgroups (C carriers and TT genotype). Brain activity was measured with amplitude of low-frequency fluctuation (ALFF). Results: The aMCI patients showed decreased ALFF in left inferior frontal gyrus, superior temporal gyrus and insula, while increased ALFF in right cuneus, calcarine, and bilateral posterior cingulate and precuneus. A significant interaction between diagnosis (aMCI vs. HC) and PICALM rs541458 genotype (C carriers vs. TT) on ALFF was observed mainly in the right frontal lobe, with aMCI C carriers and TT genotype in HC showing significantly lower ALFF than HC C carriers. While only negative correlation between ALFF and verbal fluency test was found in HC C carriers (r = -0.543, p = 0.030). Conclusions: This study provided preliminary evidences that PICALM rs541458 variations may modulate the spontaneous brain activity in aMCI patients.
The Genetic Risk Effects of APOE Ε4 and Novel Variants on Chinese Familial and Sporadic AD.

Jianping Jia,Longfei Jia,Jie Lu,Hui Xu,Fangyu Li,Shuoqi Chen,Xiu Wang,Jianwei Yang,Wei Qin,Qiumin Qu,Lan Chu,Yan-Jiang Wang,Lu Shen,Chunkui Zhou,Honglei Li,Dantao Peng,Lan Tan,Benyan Luo,Qihao Guo,Muni Tang

DOI: https://doi.org/10.1002/alz.053544

2021-01-01

Abstract:APOE ε4 positive genotype may cause familial aggregation, and the investigation of multiple interventions targeting APOE pathological function to reduce the risk for this disease warrants attention. This is the first study to validate GWAS-based predictive models for evaluating the risk of AD onset in a large Chinese population. The clinical application of these models will be beneficial for individuals harbouring these risk variants.
Implication of CLU Gene Polymorphisms in Chinese Patients with Alzheimer's Disease.

Jin-Tai Yu,Lu Li,Qi-Xiu Zhu,Qun Zhang,Wei Zhang,Zhong-Chen Wu,Jun Guan,Lan Tan

DOI: https://doi.org/10.1016/j.cca.2010.06.013

IF: 6.314

2010-01-01

Clinica Chimica Acta

Abstract:Background: Clusterin (also called apolipoprotein J) has a potential central role in the pathogenesis of Alzheimer's disease (AD). Recently, two genome-wide association studies have identified three variants in CLU gene encoding clusterin associated with AD risk in Caucasians, while there are no studies on the association of CLU with AD risk in Asians.Methods: The study investigated 324 sporadic late-onset AD (LOAD) and 388 healthy controls matched for sex and age in a Han Chinese population. Three common genetic variants (rs2279590, rs11136000 and rs9331888) in CLU gene were genotyped using MALDI-TOF mass spectrometry.Results: The minor allele (G) of the rs9331888 polymorphism within CLU was significantly associated with an increased risk of LOAD (OR = 1.39.95% Cl = 1.13-1.72, P=0.002). Logistic regression analysis revealed that the rs9331888 polymorphism presented strong associations with LOAD in the dominant, recessive and additive models. No significant differences in genotype and allele frequencies of the rs2279590 and rs11136000 polymorphisms were found between LOAD patients and controls. Haplotype analysis identified a risk haplotype (CCG) (OR= 1.66) and a protective haplotype (CCC)(OR = 0.70).Conclusions: Our findings implicate CLU as a susceptibility gene for LOAD in Han Chinese. (C) 2010 Elsevier B.V. All rights reserved.
Phosphatidylinositol Binding Clathrin Assembly Protein Gene rs3851179G/A Polymorphisms and Risk of Alzheimer's Disease

MAO Cai-Xia,SUN Fu-Rong,YU Jin-Tai,WU Zhong-Chen,ZHANG Qun,ZHANG Wei,TAN Lan

2010-01-01

Abstract:Aim:To elucidate the role of phosphatidylinositol binding clathrin assembly protein(PICALM) as a potential cause of Alzheimer's disease(AD) susceptibility in Han Chinese partial population.Methods:A casecontrol study was taken from 266 AD patients and 343 healthy controls matched for age and sex.The functional polymorphisms of rs3851179 in PICALM gene were analyzed by using polymerase chain reaction(PCR) and the products were directly sequenced.The association of the genotype and allele frequencies with the risk of AD was elucidated.Results:Neither differences of genotype frequency nor allele frequency was statistical significance between AD and controls(P>0.05).No statistical significant was found in difference of frequency between AD and controls after samples were stratified by apolipoprotein E(ApoE)ε4(P>0.05).After adjusted for age,gender,BMI,fasting glucose levels,blood pressure values,lipid levels,and the carriage of at least one ApoEε4 allele.Logistic regression analysis demonstrated odds ratio(OR) was 0.85(95%CI=0.60-1.19).Conclution:No association was found between rs3851179 polymorphism and AD in Chinese Han population.
Association of Cd33 and Ms4a Cluster Variants with Alzheimer'S Disease in East Asian Populations

Zhang-Yu Guo

DOI: https://doi.org/10.1016/j.neulet.2015.10.007

IF: 3.197

2015-01-01

Neuroscience Letters

Abstract:CD33 and MS4A cluster variants have been identified to modulate the risk of Alzheimer's disease (AD) in several recent genome-wide association studies (GWAS) in Caucasians. In the present study, we first conducted a case-control study to investigate the CD33 single nucleotide polymorphisms (SNPs) rs3865444 and rs3826656 and the MS4A cluster SNPs rs610932 and rs670139 in a cohort from eastern China that comprised 126 late-onset Alzheimer's disease (LOAD) patients and 129 healthy controls. The results revealed that the frequency of rs3826656 major (G) allele carriers was higher among the LOAD patients than among the controls [P = 0.005; odds ratio (OR), 1.760; 95% confidence interval (CI), 1.185-2.615]. In apolipoprotein E (APOE) epsilon 4 allele carriers, the G allele of the SNP rs3865444 was found to be associated with an increased risk of LOAD (P = 0.002; OR, 3.391; 95% CI, 1.512-7.605). Next, we re-evaluated the association between these variants and LOAD by conducting a meta-analysis using data from studies of East Asian populations, including the present case-control study, and confirmed that rs3826656 increased the risk of LOAD. In addition, we identified a significant association between rs610932 and LOAD (P = 0.035; OR, 0.79; 95% Cl, 0.63-0.98). Note that heterogeneity should be considered during the interpretation of these results; significant heterogeneity was identified among studies on rs3865444, even in a subgroup analysis based on stratification of studies by the country of origin. In summary, our results suggest that CD33 and MS4A cluster variants are associated with LOAD susceptibility in East Asian populations. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Effect of CLU Genetic Variants on Cerebrospinal Fluid and Neuroimaging Markers in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Cohorts

Xi-Chen Zhu,Hui-Fu Wang,Teng Jiang,Huan Lu,Meng-Shan Tan,Chen-Chen Tan,Lin Tan,Lan Tan,Jin-Tai Yu,Alzheimer’s Disease Neuroimaging Initiative

DOI: https://doi.org/10.1038/srep26027

IF: 4.6

2016-01-01

Scientific Reports

Abstract:The Clusterin (CLU) gene, also known as apolipoprotein J (ApoJ), is currently the third most associated late-onset Alzheimer’s disease (LOAD) risk gene. However, little was known about the possible effect of CLU genetic variants on AD pathology in brain. Here, we evaluated the interaction between 7 CLU SNPs (covering 95% of genetic variations) and the role of CLU in β-amyloid (Aβ) deposition, AD-related structure atrophy, abnormal glucose metabolism on neuroimaging and CSF markers to clarify the possible approach by that CLU impacts AD. Finally, four loci (rs11136000, rs1532278, rs2279590, rs7982) showed significant associations with the Aβ deposition at the baseline level while genotypes of rs9331888 (P = 0.042) increased Aβ deposition. Besides, rs9331888 was significantly associated with baseline volume of left hippocampus (P = 0.014). We then further validated the association with Aβ deposition in the AD, mild cognitive impairment (MCI), normal control (NC) sub-groups. The results in sub-groups confirmed the association between CLU genotypes and Aβ deposition further. Our findings revealed that CLU genotypes could probably modulate the cerebral the Aβ loads on imaging and volume of hippocampus. These findings raise the possibility that the biological effects of CLU may be relatively confined to neuroimaging trait and hence may offer clues to AD.
Multifactorial Analysis of a Biomarker Pool for Alzheimer Disease Risk in a North Indian Population

Puneet Talwar,Sandeep Grover,Juhi Sinha,Puneet Chandna,Rachna Agarwal,Suman Kushwaha,Ritushree Kukreti

DOI: https://doi.org/10.1159/000477206

2017-01-01

Dementia and Geriatric Cognitive Disorders

Abstract:Background: Alzheimer disease (AD) is a progressive neurodegenerative disease with a complex multifactorial etiology. Here, we aim to identify a biomarker pool comprised of genetic variants and blood biomarkers as predictor of AD risk. Methods: We performed a case-control study involving 108 cases and 159 non-demented healthy controls to examine the association of multiple biomarkers with AD risk. Results: The APOE genotyping revealed that ε4 allele frequency was significantly high (p value = 0.0001, OR = 2.66, 95% CI 1.58-4.46) in AD as compared to controls, whereas ε2 (p = 0.0430, OR = 0.29, CI 0.07-1.10) was overrepresented in controls. In biochemical assays, significant differences in levels of total copper, free copper, zinc, copper/zinc ratio, iron, epidermal growth factor receptor (EGFR), leptin, and albumin were also observed. The AD risk score (ADRS) as a linear combination of 6 candidate markers involving age, education status, APOE ε4 allele, levels of iron, Cu/Zn ratio, and EGFR was created using stepwise linear discriminant analysis. The area under the ROC curve of the ADRS panel for predicting AD risk was significantly high (AUC = 0.84, p < 0.0001, 95% CI 0.78-0.89, sensitivity = 70.0%, specificity = 83.8%) compared to individual parameters. Conclusion: These findings support the multifactorial etiology of AD and demonstrate the ability of a panel involving 6 biomarkers to discriminate AD cases from non-demented healthy controls.

psychiatry,clinical neurology,geriatrics & gerontology,gerontology
Inactivation of adrenocorticotropic hormone in vitro by tissues.

I. Geschwind,C. Li

DOI: https://doi.org/10.1210/ENDO-50-2-226

IF: 5.051

1952-02-01

Endocrinology

Abstract:The fact that frequent injections of adrenocorticotropic hormon (ACTH) are necessary in order to achieve a maximum physiological or clinical effect, along with the rapid disappearance of adrenocorticotropic activity from plasma which has been demonstrated to occur after intravenous injection of the hormone (Sayers et al 1949; Greenspan el al. 1950), and the inability of Richards and Sayers (1951) to find hormonal activity in the urine indicate that the hormone is rapidly destroyed or utilized in the organism. In order to determine the contributions of various tissues to the loss of ACTH activity, a study was made of theinactivation of the adrenocorticotropic hormone in vitro by organ slices and homogenates. METHODS The data reported here were obtained in two separate series of experiments**. The first series was conducted in 1947–1948, and some of the results of these experiments have been reported elsewhere in a preliminary note (Li, 1948).
Nasogastric tube "suction-buster holes" release mucosal occlusion despite high suction.

G. Moss

IF: 4.348

1992-07-01

Surgery

Abstract:Aspiration devices can persistently malfunction if moderate (not just high) suction causes mucosal occlusion of every opening. The standard pattern of uniformly large orifices was modified by supplementing half the nasal tubes with smaller (one tenth of the area) openings. Ten pairs of postoperative patients sipped water while suction applied to their nasal tubes varied from 40 to 300 mm Hg. Unmodified tubes consistently functioned only when applied vacuum was below 60 mm Hg. At 60 mm Hg, 20% (2/10) of tubes malfunctioned, with swallows failing to return on three consecutive attempts even at this gentle level. The failure rate rose with increasing applied suction. All 10 devices evidenced persistent occlusion when the vacuum exceeded 90 mm Hg. Each adverse result was confirmed by continued malfunction when suction was increased by another 10 mm Hg. The brisk flow through large esophageal openings dramatically differs from restricted inflow. Supplementing the standard set of uniform, large-bore aspiration orifices with additional small openings results in unimpeded function over the full range of available hospital vacuum. The additional small openings permitted the turbulent evacuation characteristic of large-bore patency. No device with accessory "suction-buster" orifices malfunctioned at even the highest available suction (300 mm Hg).
CLU rs9331888 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Caucasian But Not East Asian Populations

Shuyan Zhang,Xuling Li,Guoda Ma,Yongshuai Jiang,Mingzhi Liao,Rennan Feng,Liangcai Zhang,Jiafeng Liu,Guangyu Wang,Bin Zhao,Qinghua Jiang,Keshen Li,Guiyou Liu

DOI: https://doi.org/10.1007/s12035-015-9098-1

Abstract:Large-scale genome-wide association studies (GWAS) identified three single nucleotide polymorphisms rs11136000, rs2279590, and rs9331888 in CLU gene to be significantly associated with Alzheimer's disease (AD) in Caucasian ancestry. Both rs11136000 and rs2279590 variants were successfully replicated in Asian population. However, previous studies reported either a weak association or no association between rs9331888 polymorphism and AD in Asian population. Here, we searched the PubMed, AlzGene, and Google Scholar databases. We selected 12 independent studies that evaluated the association between the rs9331888 polymorphism and AD using a case-control design. Using an additive model, we did not identify significant heterogeneity among these 12 studies. We observed significant association between rs9331888 polymorphism and AD in pooled populations (P = 2.26E - 07, odds ratio (OR) = 1.10, 95% confidence interval (CI) 1.06-1.14). In subgroup analysis, we did not identify significant heterogeneity in both Asian and Caucasian populations. We identified significant association in Caucasian population (P = 1.67E - 08, OR = 1.13, 95% CI 1.08-1.18) but not in East Asian population (P = 0.49, OR = 1.02, 95% CI 0.96-1.10).
An exploratory study on CLU, CR1 and PICALM and Parkinson disease

Jianjun Gao,Xuemei Huang,Yikyung Park,Albert Hollenbeck,Honglei Chen

DOI: https://doi.org/10.1371/journal.pone.0024211

IF: 3.7

PLoS ONE

Abstract:Background: Recent GWAS and subsequent confirmation studies reported several single-nucleotide polymorphisms (SNPs) at the CLU, CR1 and PICALM loci in association with late-onset Alzheimer's disease (AD). Parkinson disease (PD) shares several clinical and pathologic characteristics with AD; we therefore explored whether these SNPs were also associated with PD risk. Methodology/principal findings: 791 non-Hispanic Whites cases and 1,580 matched controls were included in the study. Odds ratios (OR) and 95% confidence intervals (CI) were obtained from logistic regression models. rs11136000 at the CLU locus was associated with PD risk under the recessive model (comparing TT versus CC+CT: OR = 0.71, 95% CI: 0.55-0.92, p = 0.008) after adjusting for year of birth, gender, smoking, and caffeine intake. Further adjustment for family history of PD and ApoE ε4 status did not change the result. In addition, we did not find evidence for effect modification by ApoE or known PD risk factors. The association, however, appeared to be stronger for PD with dementia (OR = 0.49, 95% CI: 0.27-0.91) than for PD without dementia (OR = 0.81, 95% CI: 0.61-1.06). The two other SNPs, rs6656401 from CR1, and rs3851179 from PICALM region were not associated with PD (p>0.05). Conclusion: Our exploratory analysis suggests an association of CLU with PD. This exploratory finding and the role of dementia in explaining this finding needs further investigation.
Link of BIN1, CLU, and IDE Gene Polymorphisms with the Susceptibility of Alzheimer's Disease: Evidence from a Meta-analysis

Md Abdul Aziz,Ghulam Md Ashraf,Mohammad Safiqul Islam

DOI: https://doi.org/10.2174/1567205019666220511140955

Abstract:Background: Alzheimer's disease (AD) is the most common form of neurodegenerative disorder. The association of BIN1, CLU, and IDE genetic polymorphisms with AD risk have been evaluated overtimes that produced conflicting outcomes. Objective: We performed this meta-analysis to investigate the contribution of BIN1 (rs744373 and rs7561528), CLU (rs11136000 and rs9331888), and IDE (rs1887922) polymorphisms to AD risk. Methods: From a systemic literature search up to July 15, 2021, we included 25 studies with rs744373, 16 studies with rs7561528, 37 studies with rs11136000, 16 studies with rs9331888, and 4 studies with rs1887922. To analyze the correlation, we constructed seven genetic models that used odds ratio and 95% confidence intervals. We used RevMan 5.4 for meta-analysis. Results: Our study suggests that BIN1 rs744373 is associated with a significantly increased risk of AD in five genetic models (OR>1). Again, CLU rs11136000 showed reduced association in all genetic models (OR<1). CLU rs9331888 revealed an increased association in two models (OR>1). The IDE rs1887922 showed significantly increased risk in four models (OR>1). From subgroup analysis, a significantly increased risk of AD was observed in Caucasians and Asians for BIN1 rs744373. Again, BIN1 rs7561528 showed a significantly enhanced risk of AD only in Caucasians. CLU rs11136000 showed significantly reduced risk in Caucasians but rs9331888 showed increased risk in the same ethnicity. Conclusion: Our meta-analysis confirms the association of BIN1 rs744373, CLU rs9331888, and IDE rs1887922 polymorphisms with an increased risk of AD, especially in Caucasians. Again, CLU rs11136000 is associated with reduced AD risk in the overall population and Caucasians.
Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals

Thomas M Lancaster,Lisa M Brindley,Katherine E Tansey,Rebecca C Sims,Kiran Mantripragada,Michael J Owen,Julie Williams,David E J Linden

DOI: https://doi.org/10.1016/j.jalz.2014.10.012

Abstract:Introduction: Genome-wide association studies identify rs11136000 in the CLU gene, which codes for Apolipoprotein J/Clusterin, as a significant risk variant for Alzheimer's disease (AD). However, the mechanisms by which this variant confers susceptibility remain relatively unknown. Methods: Eighty-five healthy Caucasian participants underwent functional magnetic resonance imaging during a working memory (WM) task and were genotyped for CLU rs11136000/APOE loci. Results: Here we show that young individuals with the CLU rs11136000 risk variant (C) have higher activation levels in memory-related prefrontal and limbic areas during a WM task. We also found subtle reductions in gray matter in the right hippocampal formation in carriers of the risk variant. Discussion: We suggest that this pattern of multimodal imaging results may reflect incipient structural differences and inefficient functional activation. This study supports accumulating evidence suggesting that genetic risk for AD affects the neural networks associated with memory in healthy individuals.
LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION

Aysu Sen,Mehtap Arslan,Mehmet Emin Erdal,Ozlem Izci Ay,Senay Gorucu Yilmaz,Erhan Kurt,Baki Arpaci

2015-03-30

Abstract:Background and purpose: To investigate the association between the rs11136000 single nucleotide polymorphism (SNP) of the clusterin (CLU) gene, the rs541458 and rs3851179 SNPs of the phosphatidylinositol-binding clathrin assembly protein (PICALM) gene and Alzheimer's disease (AD) in a Turkish population, and to determine whether there are any relationships between the CLU and the PICALM genotypes and behavioral and psychological symptoms of dementia (BPSD) in the Turkish population. Methods: One-hundred and twelve AD patients and 106 controls were included in this study. BPSD were evaluated by the Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD). SNPs in the CLU and the PICALM gene were genotyped by Real-Time PCR. Genotype distributions were assessed for the groups of patients and controls, for the patient groups with and without each BPSD, and "No BPSD" and "BPSD". Results: The CLU and the PICALM genotypes were similar in the AD and control subjects, and the groups with and without each BPSD. There were also no significant differences between the "No BPSD" and the "BPSD" groups for the PICALM genotypes, but even without a statistical significance, it is notable that none of the "No BPSD" patients had genotype pattern CLU-rs11136000-TT, and the female subjects with genotype pattern CLU-rs11136000-TT had higher mean score of BEHAVE-AD. Conclusion: This study claims that investigated SNPs are not genetic risk factors for AD in a Turkish population. In addition, the rs541458 and rs3851179 of PICALM SNPs are not related to development of BPSD, but the rs11136000 of CLU SNP might be related to development of BPSD in AD female Turkish subpopulation.
On the nomenclature of the fluorescent substances produced in the culture of Eremothecium ashbyii.

S. Kuwada,T. Masuda,T. Kishi,M. Asai

DOI: https://doi.org/10.1248/CPB.6.447

1958-08-15

Chemical and Pharmaceutical Bulletin

Abstract:
Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population

Aleksandra Klimkowicz-Mrowiec,Małgorzata Sado,Anna Dziubek,Tomasz Dziedzic,Joanna Pera,Andrzej Szczudlik,Agnieszka Slowik

DOI: https://doi.org/10.5114/ninp.2013.33825

Abstract:Background and purpose: Recent genome-wide association studies have indicated 3 new susceptibility loci for Alzheimer disease (AD): complement receptor 1 (CR1), clusterin (CLU), and the phosphatidylinositol-binding clathrin assembly protein (PICALM). We investigated the influence of the rs6656401 single nucleotide polymorphisms (SNP) of the CR1 gene, the rs3851179 SNP of the PICALM gene, and the rs11136000 SNP of the CLU gene on risk of AD in a Polish population. Material and methods: In 253 Caucasian AD patients and 240 controls, analyses identifying the rs6656401, rs3851179 and rs11136000 SNPs and APOE common polymorphisms were performed. Results: No significant differences were observed in the distribution of the rs6656401 of CR1, rs3851179 of PICALM and rs11136000 of CLU SNPs between AD patients and controls. The APOE ε4 common polymorphism was strongly re-lated to the risk of AD. Conclusion: Our results suggest that investigated SNPs are not associated with AD in a Polish population.
Association of Apolipoprotein E (APOE) Polymorphisms With Serological Lipid and Inflammatory Markers

Hari K Krishnamurthy,Imbaasree Rajavelu,Swarnkumar Reddy,Michelle Pereira,Vasanth Jayaraman,Karthik Krishna,Qi Song,Tianhao Wang,Kang Bei,John J Rajasekaran

DOI: https://doi.org/10.7759/cureus.60721

2024-05-20

Cureus

Abstract:Background The study aims to assess the association of apolipoprotein E (APOE) gene polymorphisms with serological lipid and inflammatory markers to determine their potential role in predicting the risk of cardiovascular diseases (CVDs) and Alzheimer's disease (AD). Methodology A total of 915 individuals underwent testing for lipid and inflammatory biomarkers at Vibrant America Clinical Laboratory. Clinical data, blood lipid and inflammatory profiles, and APOE genotyping were analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results Compared to the E3/E3 genotype, individuals with E2/E3 genotypes showed higher levels of high-density lipoprotein (HDL), triglycerides, apolipoprotein A (APOA), high-sensitivity C-reactive protein (hs-CRP), and myeloperoxidase (MPO). E2/E4 genotype carriers had higher levels of HDL, triglycerides, Lp(a), and N-terminal pro b-type natriuretic peptide (BNPNT). E3/E4 genotypes were associated with elevated levels of total cholesterol, LDL, Lp(a), hs-CRP, small-density low-density lipoprotein (SDLDL), oxidized LDL (OXLDL), MPO, LDL-CAL, PLAC, and APOB. The E4/E4 group displayed higher concentrations of total cholesterol, LDL, APOB, Lp(a), hs-CRP, SDLDL, OXLDL, MPO, LDLCAL, and PLAC compared to E3/E3 carriers. These findings highlight the potential atherogenic effect of the ε4 allele and the protective effect of the ε2 allele based on lipid and inflammatory marker profiles. Conclusions This study provides strong evidence linking APOE gene polymorphism to abnormal serum lipid and inflammatory profiles. Individuals carrying the ε4 alleles exhibited dysregulated lipid metabolism and abnormal inflammatory markers, increasing their risk of CVD and AD. Early detection and prompt diagnosis are crucial for implementing therapeutic, dietary, and lifestyle interventions to mitigate risks and prevent or delay lipid and inflammation-related disorders.
Improved validated assay for the determination of proguanil and its metabolites in plasma, whole blood, and urine using solid-phase extraction and high-performance liquid chromatography.

Y. Bergqvist,L. Funding,B. Krysén,T. Leek,K. Yvell

DOI: https://doi.org/10.1097/00007691-199806000-00014

1998-06-01

Therapeutic Drug Monitoring

Abstract:An improved and validated method is presented for the determination of proguanil, cycloguanil, and 4-chlorophenylbiguanide in plasma, whole blood, and urine using solid-phase extraction (SPE) technique and reversed-phase high-performance liquid chromatography (HPLC). The HPLC method uses isocratic elution with acetonitrile:phosphate buffer 0.1 mol/l, pH 2.6 (21.5:78.5 vol/vol) at a flow rate of 1.0 ml/min for the separation. The recovery of proguanil and metabolites ranged from 82% to 104%. The limit of determination was 20 nmol/l for proguanil and its metabolites in plasma and approximately 50 nmol/l for proguanil and metabolites in whole blood. Different stationary phases for HPLC and SPE were tested and the best chromatographic separation from endogenous constituents and other antimalarial drugs was achieved with cyanopropyl stationary phases.
Quality control of proliferation marker (MIB-1) in image analysis systems utilizing cell culture-based control materials.

S. Ruby,A. McNally

DOI: https://doi.org/10.1093/AJCP/106.5.634

1996-11-01

American Journal of Clinical Pathology

Abstract:Standard controls for quality control of cell growth (proliferation) assays in image analysis systems are not currently available. The authors have developed a system of controls, based on cultured and harvested human cell lines, that can mimic tissue sections. These controls help ensure quality control for the entire cell proliferation analysis process, from the initial cutting of the paraffin block through fixation, immunohistochemical staining, and interactive image analysis. The use of cell line controls is advantageous because of the greater cell population homogeneity and the volume of uniform slides that are obtainable, as opposed to the use of a heterogeneous tissue sample. This system provides an excellent means of evaluating the day-to-day performance of cell proliferation analysis and may also be adapted for use as a method of multi-institutional proficiency testing.
Genetically-mediated Grey and White Matter Alteration in Normal Elderly Individuals with the CLU-C Allele Gene

Lihua Qiu,Yong He,Hehan Tang,Yi Zhou,Jinhong Wang,Weiwei Zhang,Guangxiang Chen,Fei Zhao,Tingxue Ouyang,Bin Ju,Zhengyan Li,Lanlan Wang,Ling Zou,Qiyong Gong

DOI: https://doi.org/10.2174/1567205013666160703180531

Abstract:Background: Several genome-wide association studies have found that the rs11136000 polymorphism of the C allele (CLU-C) is associated with the risk for developing late-onset Alzheimer's disease (LOAD). However, the effects of the CLU-C/C genotype on brain structure, including gray and white matter, are not adequately understood. Objectives: We aimed to clarify the gray matter and white matter integrity changes in non-demented ageing individuals with the AD risk gene of the rs11136000 polymorphism of the C allele (CLU-C) and the correlation with cognitive performance. Methods: Voxel-based analysis was used to compare the differences in high-resolution structural T1 and diffusion tensor imaging data between 31 CLU-C/C and 15 non-CLU-C/C carriers in nondemented older adults. Results: Compared to non-CLU-C/C carriers, CLU-C homozygotes showed a reduced gray matter concentration (GMC) in the left parahippocampal gyrus, right middle frontal and temporal middle gyri, increased GMC in the left middle frontal and right fusiform gyri and increased gray matter volume (GMV) in the left middle frontal gyrus (P < 0.001). Decreased fractional anisotropy (FA) in the sub-gyral white matter of the left external capsule and left anterior cingulate and increased FA in the sub-gyral white matter of the left temporal lobe were also found in CLU-C/C genotype carriers. Moreover, the FA value in the left external capsule correlated with several cognitive measures. Conclusion: Our findings provide further evidence for the CLU risk variant as a candidate gene for AD and may serve as a pre-clinical neuroimaging phenotype of late-onset AD.

The history of rhesus prophylaxis with anti-D

Genetic Variants of PICALM Rs541458 Modulate Brain Spontaneous Activity in Older Adults with Amnestic Mild Cognitive Impairment

The Genetic Risk Effects of APOE Ε4 and Novel Variants on Chinese Familial and Sporadic AD.

Implication of CLU Gene Polymorphisms in Chinese Patients with Alzheimer's Disease.

Phosphatidylinositol Binding Clathrin Assembly Protein Gene rs3851179G/A Polymorphisms and Risk of Alzheimer's Disease

Association of Cd33 and Ms4a Cluster Variants with Alzheimer'S Disease in East Asian Populations

Effect of CLU Genetic Variants on Cerebrospinal Fluid and Neuroimaging Markers in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Cohorts

Multifactorial Analysis of a Biomarker Pool for Alzheimer Disease Risk in a North Indian Population

Inactivation of adrenocorticotropic hormone in vitro by tissues.

Nasogastric tube "suction-buster holes" release mucosal occlusion despite high suction.

CLU rs9331888 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Caucasian But Not East Asian Populations

An exploratory study on CLU, CR1 and PICALM and Parkinson disease

Link of BIN1, CLU, and IDE Gene Polymorphisms with the Susceptibility of Alzheimer's Disease: Evidence from a Meta-analysis

Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals

LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION

On the nomenclature of the fluorescent substances produced in the culture of Eremothecium ashbyii.

Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population

Association of Apolipoprotein E (APOE) Polymorphisms With Serological Lipid and Inflammatory Markers

Improved validated assay for the determination of proguanil and its metabolites in plasma, whole blood, and urine using solid-phase extraction and high-performance liquid chromatography.

Quality control of proliferation marker (MIB-1) in image analysis systems utilizing cell culture-based control materials.

Genetically-mediated Grey and White Matter Alteration in Normal Elderly Individuals with the CLU-C Allele Gene